Chemoimmunotherapy of Chronic Hepatitis B Virus Infection in the Woodchuck Model Overcomes Immunologic Tolerance and Restores T-Cell Responses to Pre-S and S Regions of the Viral Envelope Protein
- 1 October 2007
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 81 (19), 10614-10624
- https://doi.org/10.1128/jvi.00691-07
Abstract
Treatment of chronic hepatitis B virus (HBV) infection could combine potent antiviral drugs and therapeutic vaccines to overcome immunological tolerance and induce the recovery phenotype to protect against disease progression. Conventional vaccination of woodchucks chronically infected with the woodchuck hepatitis virus (WHV) elicited differential T-cell response profiles depending on whether or not carriers were treated with the potent antiviral drug clevudine (CLV), which significantly reduces viral and antigen loads. The differential T-cell responses defined both CLV-dependent and CLV-independent epitopes of the pre-S and S regions of the WHV envelope protein. Only combined treatment involving CLV and conventional vaccine therapeutically restored the T-cell response profile of chronic WHV carrier woodchucks to that seen in prophylactic vaccination and in recovery from acute WHV infection. The results have implications for mechanisms of immunological tolerance operating in chronic HBV infection and suggest that such combined chemoimmunotherapy may be useful for treatment of humans with chronic HBV infection.Keywords
This publication has 45 references indexed in Scilit:
- Immunosuppression reactivates viral replication long after resolution of woodchuck hepatitis virus infectionHepatology, 2007
- Immune Tolerance Split between Hepatitis B Virus Precore and Core ProteinsJournal of Virology, 2005
- T cell tolerance and autoimmunityAutoimmunity Reviews, 2004
- Deficiencies in the Acute-Phase Cell-Mediated Immune Response to Viral Antigens Are Associated with Development of Chronic Woodchuck Hepatitis Virus Infection following Neonatal InoculationJournal of Virology, 2002
- Immune responses during lamivudine/interferon-α combination therapy of chronic HBV infectionJournal of Hepatology, 2000
- Intrahepatic T Cells in Hepatitis BThe Journal of Experimental Medicine, 2000
- Effects of age and viral determinants on chronicity as an outcome of experimental woodchuck hepatitis virus infectionHepatology, 2000
- Induction of T-helper cell response to hepatitis B core antigen in chronic hepatitis B: A major factor in activation of the host immune response to the hepatitis B virusHepatology, 1995
- Induction of T-helper cell response to hepatitis B core antigen in chronic hepatitis B: A major factor in activation of the host immune response to the hepatitis B virusHepatology, 1995
- Proliferative response of CD4+ T cells and hepatitis B virus clearance in chronic hepatitis with or without hepatitis B e–minus hepatitis B virus mutantsHepatology, 1995